Copyright Reports & Markets. All rights reserved.

Global Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Urinary Tract Infections
    • 1.2.3 Surgical Site Infections
    • 1.2.4 Hospital-acquired Pneumonia
    • 1.2.5 BloodStream Infections
    • 1.2.6 Gastrointestinal Infections
  • 1.3 Market by Application
    • 1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 ASCs
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2016-2027)
  • 2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Regions
    • 2.2.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Share by Regions (2016-2021)
    • 2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027)
  • 2.3 Healthcare-associated Infectious Disease Diagnostics Industry Dynamic
    • 2.3.1 Healthcare-associated Infectious Disease Diagnostics Market Trends
    • 2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
    • 2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
    • 2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue
    • 3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2016-2021)
    • 3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2016-2021)
  • 3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
  • 3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
    • 3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2020
  • 3.5 Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Area Served
  • 3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
  • 3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Type

  • 4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Type (2016-2021)
  • 4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027)

5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application

  • 5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2016-2021)
  • 5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
  • 6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
    • 6.2.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
    • 6.2.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
    • 6.2.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
  • 6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
    • 6.3.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
    • 6.3.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
    • 6.3.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
  • 6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
    • 6.4.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
    • 6.4.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
  • 7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type
    • 7.2.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
    • 7.2.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
    • 7.2.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
  • 7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application
    • 7.3.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
    • 7.3.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
    • 7.3.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
  • 7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country
    • 7.4.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
    • 7.4.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
  • 8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type
    • 8.2.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application
    • 8.3.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region
    • 8.4.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
  • 9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
    • 9.2.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
    • 9.2.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
    • 9.2.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
  • 9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
    • 9.3.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
    • 9.3.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
    • 9.3.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
  • 9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
    • 9.4.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
    • 9.4.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
  • 10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type
    • 10.2.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application
    • 10.3.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country
    • 10.4.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott
    • 11.1.1 Abbott Company Details
    • 11.1.2 Abbott Business Overview
    • 11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.1.5 Abbott Recent Development
  • 11.2 Accelerate Diagnostics
    • 11.2.1 Accelerate Diagnostics Company Details
    • 11.2.2 Accelerate Diagnostics Business Overview
    • 11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.2.5 Accelerate Diagnostics Recent Development
  • 11.3 BD
    • 11.3.1 BD Company Details
    • 11.3.2 BD Business Overview
    • 11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.3.5 BD Recent Development
  • 11.4 bioMrieux
    • 11.4.1 bioMrieux Company Details
    • 11.4.2 bioMrieux Business Overview
    • 11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.4.5 bioMrieux Recent Development
  • 11.5 Bio-Rad
    • 11.5.1 Bio-Rad Company Details
    • 11.5.2 Bio-Rad Business Overview
    • 11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.5.5 Bio-Rad Recent Development
  • 11.6 DiaSorin Molecular
    • 11.6.1 DiaSorin Molecular Company Details
    • 11.6.2 DiaSorin Molecular Business Overview
    • 11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.6.5 DiaSorin Molecular Recent Development
  • 11.7 F. Hoffmann-La Roche
    • 11.7.1 F. Hoffmann-La Roche Company Details
    • 11.7.2 F. Hoffmann-La Roche Business Overview
    • 11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.7.5 F. Hoffmann-La Roche Recent Development
  • 11.8 Luminex
    • 11.8.1 Luminex Company Details
    • 11.8.2 Luminex Business Overview
    • 11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.8.5 Luminex Recent Development
  • 11.9 Meridian Bioscience
    • 11.9.1 Meridian Bioscience Company Details
    • 11.9.2 Meridian Bioscience Business Overview
    • 11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.9.5 Meridian Bioscience Recent Development
  • 11.10 OpGen
    • 11.10.1 OpGen Company Details
    • 11.10.2 OpGen Business Overview
    • 11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.10.5 OpGen Recent Development
  • 11.11 QIAGEN
    • 11.11.1 QIAGEN Company Details
    • 11.11.2 QIAGEN Business Overview
    • 11.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.11.5 QIAGEN Recent Development
  • 11.12 Quidel
    • 11.12.1 Quidel Company Details
    • 11.12.2 Quidel Business Overview
    • 11.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.12.5 Quidel Recent Development
  • 11.13 Thermo Fisher Scientific
    • 11.13.1 Thermo Fisher Scientific Company Details
    • 11.13.2 Thermo Fisher Scientific Business Overview
    • 11.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.13.5 Thermo Fisher Scientific Recent Development
  • 11.14 Trinity Biotech
    • 11.14.1 Trinity Biotech Company Details
    • 11.14.2 Trinity Biotech Business Overview
    • 11.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.14.5 Trinity Biotech Recent Development
  • 11.15 Danaher
    • 11.15.1 Danaher Company Details
    • 11.15.2 Danaher Business Overview
    • 11.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    • 11.15.5 Danaher Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Healthcare-associated Infectious Disease Diagnostics Scope and Market Size
    Healthcare-associated Infectious Disease Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Healthcare-associated Infectious Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Urinary Tract Infections
    Surgical Site Infections
    Hospital-acquired Pneumonia
    BloodStream Infections
    Gastrointestinal Infections

    Segment by Application
    Hospitals
    Clinics
    ASCs

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Abbott
    Accelerate Diagnostics
    BD
    bioMrieux
    Bio-Rad
    DiaSorin Molecular
    F. Hoffmann-La Roche
    Luminex
    Meridian Bioscience
    OpGen
    QIAGEN
    Quidel
    Thermo Fisher Scientific
    Trinity Biotech
    Danaher

    Buy now